averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Name | miRBASE accession |
---|---|
hsa-miR-142-5p
|
MIMAT0000433 |
hsa-miR-5590-3p
|
MIMAT0022300 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_+_36572851 | 17.30 |
ENST00000298048.2
ENST00000538311.1 ENST00000536987.1 ENST00000545008.1 ENST00000536860.1 ENST00000536329.1 ENST00000541717.1 ENST00000543751.1 |
MELK
|
maternal embryonic leucine zipper kinase |
chr5_+_95997918 | 16.84 |
ENST00000395812.2
ENST00000395813.1 ENST00000359176.4 ENST00000325674.7 |
CAST
|
calpastatin |
chr7_+_26240776 | 15.49 |
ENST00000337620.4
|
CBX3
|
chromobox homolog 3 |
chr13_+_76123883 | 13.93 |
ENST00000377595.3
|
UCHL3
|
ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase) |
chr1_+_116184566 | 13.07 |
ENST00000355485.2
ENST00000369510.4 |
VANGL1
|
VANGL planar cell polarity protein 1 |
chr1_-_67896095 | 12.83 |
ENST00000370994.4
|
SERBP1
|
SERPINE1 mRNA binding protein 1 |
chr2_+_114647504 | 12.50 |
ENST00000263238.2
|
ACTR3
|
ARP3 actin-related protein 3 homolog (yeast) |
chrX_-_20284958 | 12.46 |
ENST00000379565.3
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
chr6_-_18265050 | 12.10 |
ENST00000397239.3
|
DEK
|
DEK oncogene |
chr16_-_47177874 | 11.43 |
ENST00000562435.1
|
NETO2
|
neuropilin (NRP) and tolloid (TLL)-like 2 |
chr15_+_77223960 | 11.37 |
ENST00000394885.3
|
RCN2
|
reticulocalbin 2, EF-hand calcium binding domain |
chr17_+_57784826 | 11.21 |
ENST00000262291.4
|
VMP1
|
vacuole membrane protein 1 |
chr19_+_39138271 | 11.08 |
ENST00000252699.2
|
ACTN4
|
actinin, alpha 4 |
chr12_-_102513843 | 10.80 |
ENST00000551744.2
ENST00000552283.1 |
NUP37
|
nucleoporin 37kDa |
chr2_-_153574480 | 10.68 |
ENST00000410080.1
|
PRPF40A
|
PRP40 pre-mRNA processing factor 40 homolog A (S. cerevisiae) |
chr17_-_73179046 | 10.58 |
ENST00000314523.7
ENST00000420826.2 |
SUMO2
|
small ubiquitin-like modifier 2 |
chr15_+_52311398 | 10.54 |
ENST00000261845.5
|
MAPK6
|
mitogen-activated protein kinase 6 |
chr10_+_28966271 | 10.49 |
ENST00000375533.3
|
BAMBI
|
BMP and activin membrane-bound inhibitor |
chr8_-_103668114 | 10.32 |
ENST00000285407.6
|
KLF10
|
Kruppel-like factor 10 |
chr3_+_150321068 | 10.14 |
ENST00000471696.1
ENST00000477889.1 ENST00000485923.1 |
SELT
|
Selenoprotein T |
chr1_-_205719295 | 9.70 |
ENST00000367142.4
|
NUCKS1
|
nuclear casein kinase and cyclin-dependent kinase substrate 1 |
chr5_+_32585605 | 8.97 |
ENST00000265073.4
ENST00000515355.1 ENST00000502897.1 ENST00000510442.1 |
SUB1
|
SUB1 homolog (S. cerevisiae) |
chr3_-_79068594 | 8.21 |
ENST00000436010.2
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila) |
chr15_+_57210818 | 8.10 |
ENST00000438423.2
ENST00000267811.5 ENST00000452095.2 ENST00000559609.1 ENST00000333725.5 |
TCF12
|
transcription factor 12 |
chr2_-_26101374 | 8.08 |
ENST00000435504.4
|
ASXL2
|
additional sex combs like 2 (Drosophila) |
chr2_+_201676256 | 7.96 |
ENST00000452206.1
ENST00000410110.2 ENST00000409600.1 |
BZW1
|
basic leucine zipper and W2 domains 1 |
chr10_+_3109695 | 7.84 |
ENST00000381125.4
|
PFKP
|
phosphofructokinase, platelet |
chr3_-_72496035 | 7.60 |
ENST00000477973.2
|
RYBP
|
RING1 and YY1 binding protein |
chr2_+_99953816 | 7.55 |
ENST00000289371.6
|
EIF5B
|
eukaryotic translation initiation factor 5B |
chr3_-_183966717 | 7.43 |
ENST00000446569.1
ENST00000418734.2 ENST00000397676.3 |
ALG3
|
ALG3, alpha-1,3- mannosyltransferase |
chr12_-_117628333 | 7.42 |
ENST00000427718.2
|
FBXO21
|
F-box protein 21 |
chr2_+_48010221 | 7.37 |
ENST00000234420.5
|
MSH6
|
mutS homolog 6 |
chr1_+_112162381 | 7.34 |
ENST00000433097.1
ENST00000369709.3 ENST00000436150.2 |
RAP1A
|
RAP1A, member of RAS oncogene family |
chr17_-_62502639 | 7.31 |
ENST00000225792.5
ENST00000581697.1 ENST00000584279.1 ENST00000577922.1 |
DDX5
|
DEAD (Asp-Glu-Ala-Asp) box helicase 5 |
chr22_+_38597889 | 6.98 |
ENST00000338483.2
ENST00000538320.1 ENST00000538999.1 ENST00000441709.1 |
MAFF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
chr8_-_103876965 | 6.95 |
ENST00000337198.5
|
AZIN1
|
antizyme inhibitor 1 |
chr3_-_160283348 | 6.95 |
ENST00000334256.4
|
KPNA4
|
karyopherin alpha 4 (importin alpha 3) |
chr19_-_13068012 | 6.94 |
ENST00000316939.1
|
GADD45GIP1
|
growth arrest and DNA-damage-inducible, gamma interacting protein 1 |
chr14_+_105219437 | 6.41 |
ENST00000329967.6
ENST00000347067.5 ENST00000553810.1 |
SIVA1
|
SIVA1, apoptosis-inducing factor |
chr6_-_86352642 | 6.38 |
ENST00000355238.6
|
SYNCRIP
|
synaptotagmin binding, cytoplasmic RNA interacting protein |
chrX_-_109561294 | 6.26 |
ENST00000372059.2
ENST00000262844.5 |
AMMECR1
|
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 |
chr2_+_181845298 | 6.15 |
ENST00000410062.4
|
UBE2E3
|
ubiquitin-conjugating enzyme E2E 3 |
chr1_-_65432171 | 5.96 |
ENST00000342505.4
|
JAK1
|
Janus kinase 1 |
chr10_+_89622870 | 5.73 |
ENST00000371953.3
|
PTEN
|
phosphatase and tensin homolog |
chr2_-_161350305 | 5.67 |
ENST00000348849.3
|
RBMS1
|
RNA binding motif, single stranded interacting protein 1 |
chr16_+_69221028 | 5.56 |
ENST00000336278.4
|
SNTB2
|
syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2) |
chr7_-_23510086 | 5.55 |
ENST00000258729.3
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3 |
chr16_-_87525651 | 5.52 |
ENST00000268616.4
|
ZCCHC14
|
zinc finger, CCHC domain containing 14 |
chr3_+_52232102 | 5.36 |
ENST00000469224.1
ENST00000394965.2 ENST00000310271.2 ENST00000484952.1 |
ALAS1
|
aminolevulinate, delta-, synthase 1 |
chr2_-_242212227 | 5.33 |
ENST00000427007.1
ENST00000458564.1 ENST00000452065.1 ENST00000427183.2 ENST00000426343.1 ENST00000422080.1 ENST00000449504.1 ENST00000449864.1 ENST00000391975.1 |
HDLBP
|
high density lipoprotein binding protein |
chr13_+_98605902 | 5.26 |
ENST00000460070.1
ENST00000481455.1 ENST00000261574.5 ENST00000493281.1 ENST00000463157.1 ENST00000471898.1 ENST00000489058.1 ENST00000481689.1 |
IPO5
|
importin 5 |
chr15_-_77363513 | 5.17 |
ENST00000267970.4
|
TSPAN3
|
tetraspanin 3 |
chr17_-_40169659 | 5.15 |
ENST00000457167.4
|
DNAJC7
|
DnaJ (Hsp40) homolog, subfamily C, member 7 |
chr2_+_46769798 | 5.13 |
ENST00000238738.4
|
RHOQ
|
ras homolog family member Q |
chr6_-_24721054 | 5.00 |
ENST00000378119.4
|
C6orf62
|
chromosome 6 open reading frame 62 |
chr21_-_18985158 | 4.98 |
ENST00000339775.6
|
BTG3
|
BTG family, member 3 |
chr5_+_162932554 | 4.96 |
ENST00000321757.6
ENST00000421814.2 ENST00000518095.1 |
MAT2B
|
methionine adenosyltransferase II, beta |
chr17_+_46985731 | 4.93 |
ENST00000360943.5
|
UBE2Z
|
ubiquitin-conjugating enzyme E2Z |
chr1_+_65886262 | 4.84 |
ENST00000371065.4
|
LEPROT
|
leptin receptor overlapping transcript |
chr10_+_105726862 | 4.67 |
ENST00000335753.4
ENST00000369755.3 |
SLK
|
STE20-like kinase |
chr5_+_151151471 | 4.62 |
ENST00000394123.3
ENST00000543466.1 |
G3BP1
|
GTPase activating protein (SH3 domain) binding protein 1 |
chr17_+_57642886 | 4.50 |
ENST00000251241.4
ENST00000451169.2 ENST00000425628.3 ENST00000584385.1 ENST00000580030.1 |
DHX40
|
DEAH (Asp-Glu-Ala-His) box polypeptide 40 |
chr18_-_51751132 | 4.47 |
ENST00000256429.3
|
MBD2
|
methyl-CpG binding domain protein 2 |
chr3_+_30648066 | 4.47 |
ENST00000359013.4
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa) |
chr5_+_10353780 | 4.46 |
ENST00000449913.2
ENST00000503788.1 ENST00000274140.5 |
MARCH6
|
membrane-associated ring finger (C3HC4) 6, E3 ubiquitin protein ligase |
chr5_+_179159813 | 4.45 |
ENST00000292599.3
|
MAML1
|
mastermind-like 1 (Drosophila) |
chr7_+_156931606 | 4.42 |
ENST00000348165.5
|
UBE3C
|
ubiquitin protein ligase E3C |
chr15_-_37390482 | 4.32 |
ENST00000559085.1
ENST00000397624.3 |
MEIS2
|
Meis homeobox 2 |
chr6_-_79787902 | 4.31 |
ENST00000275034.4
|
PHIP
|
pleckstrin homology domain interacting protein |
chr19_-_1568057 | 4.25 |
ENST00000402693.4
ENST00000388824.6 |
MEX3D
|
mex-3 RNA binding family member D |
chr8_+_30013813 | 4.20 |
ENST00000221114.3
|
DCTN6
|
dynactin 6 |
chr3_+_107241783 | 4.12 |
ENST00000415149.2
ENST00000402543.1 ENST00000325805.8 ENST00000427402.1 |
BBX
|
bobby sox homolog (Drosophila) |
chr14_+_100705322 | 4.01 |
ENST00000262238.4
|
YY1
|
YY1 transcription factor |
chr22_-_50217981 | 3.95 |
ENST00000457780.2
|
BRD1
|
bromodomain containing 1 |
chr17_-_46623441 | 3.88 |
ENST00000330070.4
|
HOXB2
|
homeobox B2 |
chr12_-_14133053 | 3.87 |
ENST00000609686.1
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
chr6_-_36515177 | 3.86 |
ENST00000229812.7
|
STK38
|
serine/threonine kinase 38 |
chr17_+_28804380 | 3.84 |
ENST00000225724.5
ENST00000451249.2 ENST00000467337.2 ENST00000581721.1 ENST00000414833.2 |
GOSR1
|
golgi SNAP receptor complex member 1 |
chrX_-_134049262 | 3.81 |
ENST00000370783.3
|
MOSPD1
|
motile sperm domain containing 1 |
chr15_+_66161871 | 3.73 |
ENST00000569896.1
|
RAB11A
|
RAB11A, member RAS oncogene family |
chr4_-_74124502 | 3.64 |
ENST00000358602.4
ENST00000330838.6 ENST00000561029.1 |
ANKRD17
|
ankyrin repeat domain 17 |
chr1_-_113249948 | 3.56 |
ENST00000339083.7
ENST00000369642.3 |
RHOC
|
ras homolog family member C |
chr8_+_98656336 | 3.55 |
ENST00000336273.3
|
MTDH
|
metadherin |
chr1_+_27022485 | 3.54 |
ENST00000324856.7
|
ARID1A
|
AT rich interactive domain 1A (SWI-like) |
chr3_+_187930719 | 3.53 |
ENST00000312675.4
|
LPP
|
LIM domain containing preferred translocation partner in lipoma |
chr12_+_64798095 | 3.50 |
ENST00000332707.5
|
XPOT
|
exportin, tRNA |
chr1_-_245027833 | 3.41 |
ENST00000444376.2
|
HNRNPU
|
heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) |
chr12_-_26278030 | 3.37 |
ENST00000242728.4
|
BHLHE41
|
basic helix-loop-helix family, member e41 |
chr18_-_18691739 | 3.36 |
ENST00000399799.2
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1 |
chr3_+_69812877 | 3.33 |
ENST00000457080.1
ENST00000328528.6 |
MITF
|
microphthalmia-associated transcription factor |
chr11_+_93517393 | 3.19 |
ENST00000251871.3
ENST00000530819.1 |
MED17
|
mediator complex subunit 17 |
chr12_-_92539614 | 3.19 |
ENST00000256015.3
|
BTG1
|
B-cell translocation gene 1, anti-proliferative |
chr3_-_52713729 | 3.18 |
ENST00000296302.7
ENST00000356770.4 ENST00000337303.4 ENST00000409057.1 ENST00000410007.1 ENST00000409114.3 ENST00000409767.1 ENST00000423351.1 |
PBRM1
|
polybromo 1 |
chr14_-_23540747 | 3.15 |
ENST00000555566.1
ENST00000338631.6 ENST00000557515.1 ENST00000397341.3 |
ACIN1
|
apoptotic chromatin condensation inducer 1 |
chr1_+_16174280 | 3.15 |
ENST00000375759.3
|
SPEN
|
spen family transcriptional repressor |
chr2_+_120517174 | 3.14 |
ENST00000263708.2
|
PTPN4
|
protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte) |
chr20_-_62601218 | 3.12 |
ENST00000369888.1
|
ZNF512B
|
zinc finger protein 512B |
chr10_+_82213904 | 3.05 |
ENST00000429989.3
|
TSPAN14
|
tetraspanin 14 |
chr18_+_3247413 | 3.02 |
ENST00000579226.1
ENST00000217652.3 |
MYL12A
|
myosin, light chain 12A, regulatory, non-sarcomeric |
chr21_-_43346790 | 2.94 |
ENST00000329623.7
|
C2CD2
|
C2 calcium-dependent domain containing 2 |
chr3_+_105085734 | 2.88 |
ENST00000306107.5
|
ALCAM
|
activated leukocyte cell adhesion molecule |
chr4_-_25864581 | 2.86 |
ENST00000399878.3
|
SEL1L3
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
chr2_-_37899323 | 2.85 |
ENST00000295324.3
ENST00000457889.1 |
CDC42EP3
|
CDC42 effector protein (Rho GTPase binding) 3 |
chr1_+_87380299 | 2.77 |
ENST00000370551.4
ENST00000370550.5 |
HS2ST1
|
heparan sulfate 2-O-sulfotransferase 1 |
chr12_-_75905374 | 2.67 |
ENST00000438169.2
ENST00000229214.4 |
KRR1
|
KRR1, small subunit (SSU) processome component, homolog (yeast) |
chr18_-_45456930 | 2.61 |
ENST00000262160.6
ENST00000587269.1 |
SMAD2
|
SMAD family member 2 |
chr8_-_130951940 | 2.54 |
ENST00000522250.1
ENST00000522941.1 ENST00000522746.1 ENST00000520204.1 ENST00000519070.1 ENST00000520254.1 ENST00000519824.2 ENST00000519540.1 |
FAM49B
|
family with sequence similarity 49, member B |
chr22_-_38669030 | 2.54 |
ENST00000361906.3
|
TMEM184B
|
transmembrane protein 184B |
chr3_+_150126101 | 2.53 |
ENST00000361875.3
ENST00000361136.2 |
TSC22D2
|
TSC22 domain family, member 2 |
chr8_+_64081118 | 2.53 |
ENST00000539294.1
|
YTHDF3
|
YTH domain family, member 3 |
chr22_+_38093005 | 2.51 |
ENST00000406386.3
|
TRIOBP
|
TRIO and F-actin binding protein |
chr8_-_53626974 | 2.51 |
ENST00000435644.2
ENST00000518710.1 ENST00000025008.5 ENST00000517963.1 |
RB1CC1
|
RB1-inducible coiled-coil 1 |
chr4_+_17616253 | 2.50 |
ENST00000237380.7
|
MED28
|
mediator complex subunit 28 |
chr7_-_94285511 | 2.48 |
ENST00000265735.7
|
SGCE
|
sarcoglycan, epsilon |
chr6_-_111804393 | 2.41 |
ENST00000368802.3
ENST00000368805.1 |
REV3L
|
REV3-like, polymerase (DNA directed), zeta, catalytic subunit |
chr16_+_53088885 | 2.38 |
ENST00000566029.1
ENST00000447540.1 |
CHD9
|
chromodomain helicase DNA binding protein 9 |
chr11_-_6633799 | 2.37 |
ENST00000299424.4
|
TAF10
|
TAF10 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 30kDa |
chr1_-_53018654 | 2.36 |
ENST00000257177.4
ENST00000355809.4 ENST00000528642.1 ENST00000470626.1 ENST00000371544.3 |
ZCCHC11
|
zinc finger, CCHC domain containing 11 |
chr19_-_10305752 | 2.33 |
ENST00000540357.1
ENST00000359526.4 ENST00000340748.4 |
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1 |
chr1_-_31538517 | 2.29 |
ENST00000440538.2
ENST00000423018.2 ENST00000424085.2 ENST00000426105.2 ENST00000257075.5 ENST00000373747.3 ENST00000525843.1 ENST00000373742.2 |
PUM1
|
pumilio RNA-binding family member 1 |
chr17_+_30469473 | 2.29 |
ENST00000333942.6
ENST00000358365.3 ENST00000583994.1 ENST00000545287.2 |
RHOT1
|
ras homolog family member T1 |
chr14_-_35099315 | 2.29 |
ENST00000396526.3
ENST00000396534.3 ENST00000355110.5 ENST00000557265.1 |
SNX6
|
sorting nexin 6 |
chr4_+_147096837 | 2.28 |
ENST00000296581.5
ENST00000502781.1 |
LSM6
|
LSM6 homolog, U6 small nuclear RNA associated (S. cerevisiae) |
chr19_+_48949030 | 2.22 |
ENST00000253237.5
|
GRWD1
|
glutamate-rich WD repeat containing 1 |
chr3_+_142720366 | 2.21 |
ENST00000493782.1
ENST00000397933.2 ENST00000473835.2 ENST00000493598.2 |
U2SURP
|
U2 snRNP-associated SURP domain containing |
chr7_-_87849340 | 2.17 |
ENST00000419179.1
ENST00000265729.2 |
SRI
|
sorcin |
chr18_+_20513782 | 2.13 |
ENST00000399722.2
ENST00000399725.2 ENST00000399721.2 ENST00000583594.1 |
RBBP8
|
retinoblastoma binding protein 8 |
chr4_-_71705590 | 2.10 |
ENST00000254799.6
|
GRSF1
|
G-rich RNA sequence binding factor 1 |
chr2_+_109335929 | 2.07 |
ENST00000283195.6
|
RANBP2
|
RAN binding protein 2 |
chr12_-_120315074 | 2.07 |
ENST00000261833.7
ENST00000392521.2 |
CIT
|
citron (rho-interacting, serine/threonine kinase 21) |
chrX_+_146993449 | 2.06 |
ENST00000218200.8
ENST00000370471.3 ENST00000370477.1 |
FMR1
|
fragile X mental retardation 1 |
chr2_-_183903133 | 2.06 |
ENST00000361354.4
|
NCKAP1
|
NCK-associated protein 1 |
chr10_+_88516396 | 2.02 |
ENST00000372037.3
|
BMPR1A
|
bone morphogenetic protein receptor, type IA |
chr8_-_105601134 | 1.99 |
ENST00000276654.5
ENST00000424843.2 |
LRP12
|
low density lipoprotein receptor-related protein 12 |
chr7_+_116139424 | 1.94 |
ENST00000222693.4
|
CAV2
|
caveolin 2 |
chr2_+_187454749 | 1.94 |
ENST00000261023.3
ENST00000374907.3 |
ITGAV
|
integrin, alpha V |
chr21_-_28217721 | 1.93 |
ENST00000284984.3
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
chr3_-_197025447 | 1.92 |
ENST00000346964.2
ENST00000357674.4 ENST00000314062.3 ENST00000448528.2 ENST00000419553.1 |
DLG1
|
discs, large homolog 1 (Drosophila) |
chr12_-_76425368 | 1.87 |
ENST00000602540.1
|
PHLDA1
|
pleckstrin homology-like domain, family A, member 1 |
chr15_-_42264702 | 1.86 |
ENST00000220325.4
|
EHD4
|
EH-domain containing 4 |
chr13_-_23949671 | 1.86 |
ENST00000402364.1
|
SACS
|
spastic ataxia of Charlevoix-Saguenay (sacsin) |
chr19_+_10982189 | 1.84 |
ENST00000327064.4
ENST00000588947.1 |
CARM1
|
coactivator-associated arginine methyltransferase 1 |
chr4_-_102268628 | 1.84 |
ENST00000323055.6
ENST00000512215.1 ENST00000394854.3 |
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
chr7_+_24612935 | 1.83 |
ENST00000222644.5
|
MPP6
|
membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6) |
chr8_+_87354945 | 1.77 |
ENST00000517970.1
|
WWP1
|
WW domain containing E3 ubiquitin protein ligase 1 |
chr12_+_56137064 | 1.77 |
ENST00000257868.5
ENST00000546799.1 |
GDF11
|
growth differentiation factor 11 |
chr7_-_27213893 | 1.76 |
ENST00000283921.4
|
HOXA10
|
homeobox A10 |
chrX_-_41782249 | 1.76 |
ENST00000442742.2
ENST00000421587.2 ENST00000378166.4 ENST00000318588.9 ENST00000361962.4 |
CASK
|
calcium/calmodulin-dependent serine protein kinase (MAGUK family) |
chr18_+_2655692 | 1.66 |
ENST00000320876.6
|
SMCHD1
|
structural maintenance of chromosomes flexible hinge domain containing 1 |
chr10_+_70883908 | 1.66 |
ENST00000263559.6
ENST00000395098.1 ENST00000546041.1 ENST00000541711.1 |
VPS26A
|
vacuolar protein sorting 26 homolog A (S. pombe) |
chr2_+_202899310 | 1.65 |
ENST00000286201.1
|
FZD7
|
frizzled family receptor 7 |
chrX_-_119694538 | 1.60 |
ENST00000371322.5
|
CUL4B
|
cullin 4B |
chr3_+_15247686 | 1.60 |
ENST00000253693.2
|
CAPN7
|
calpain 7 |
chr20_+_56884752 | 1.60 |
ENST00000244040.3
|
RAB22A
|
RAB22A, member RAS oncogene family |
chr6_+_15246501 | 1.58 |
ENST00000341776.2
|
JARID2
|
jumonji, AT rich interactive domain 2 |
chr1_+_164528866 | 1.58 |
ENST00000420696.2
|
PBX1
|
pre-B-cell leukemia homeobox 1 |
chr18_+_55711575 | 1.57 |
ENST00000356462.6
ENST00000400345.3 ENST00000589054.1 ENST00000256832.7 |
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
chr1_-_27216729 | 1.56 |
ENST00000431781.2
ENST00000374135.4 |
GPN2
|
GPN-loop GTPase 2 |
chr10_-_62704005 | 1.52 |
ENST00000337910.5
|
RHOBTB1
|
Rho-related BTB domain containing 1 |
chr6_-_16761678 | 1.44 |
ENST00000244769.4
ENST00000436367.1 |
ATXN1
|
ataxin 1 |
chr9_+_119449576 | 1.43 |
ENST00000450136.1
ENST00000373983.2 ENST00000411410.1 |
TRIM32
|
tripartite motif containing 32 |
chr6_-_90062543 | 1.43 |
ENST00000435041.2
|
UBE2J1
|
ubiquitin-conjugating enzyme E2, J1 |
chr3_+_11314099 | 1.39 |
ENST00000446450.2
ENST00000354956.5 ENST00000354449.3 ENST00000419112.1 |
ATG7
|
autophagy related 7 |
chr10_-_65225722 | 1.35 |
ENST00000399251.1
|
JMJD1C
|
jumonji domain containing 1C |
chr1_-_53793584 | 1.33 |
ENST00000354412.3
ENST00000347547.2 ENST00000306052.6 |
LRP8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
chr21_-_28338732 | 1.31 |
ENST00000284987.5
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
chr11_-_44331679 | 1.30 |
ENST00000329255.3
|
ALX4
|
ALX homeobox 4 |
chr1_+_161736072 | 1.29 |
ENST00000367942.3
|
ATF6
|
activating transcription factor 6 |
chr10_+_70091812 | 1.26 |
ENST00000265866.7
|
HNRNPH3
|
heterogeneous nuclear ribonucleoprotein H3 (2H9) |
chr6_+_64281906 | 1.25 |
ENST00000370651.3
|
PTP4A1
|
protein tyrosine phosphatase type IVA, member 1 |
chr20_-_36156125 | 1.25 |
ENST00000397135.1
ENST00000397137.1 |
BLCAP
|
bladder cancer associated protein |
chr2_-_11484710 | 1.24 |
ENST00000315872.6
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2 |
chr10_+_111967345 | 1.23 |
ENST00000332674.5
ENST00000453116.1 |
MXI1
|
MAX interactor 1, dimerization protein |
chr3_+_110790590 | 1.19 |
ENST00000485303.1
|
PVRL3
|
poliovirus receptor-related 3 |
chrX_+_105937068 | 1.18 |
ENST00000324342.3
|
RNF128
|
ring finger protein 128, E3 ubiquitin protein ligase |
chr2_+_134877740 | 1.17 |
ENST00000409645.1
|
MGAT5
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase |
chr5_+_102455853 | 1.16 |
ENST00000515845.1
ENST00000321521.9 ENST00000507921.1 |
PPIP5K2
|
diphosphoinositol pentakisphosphate kinase 2 |
chr1_+_212208919 | 1.16 |
ENST00000366991.4
ENST00000542077.1 |
DTL
|
denticleless E3 ubiquitin protein ligase homolog (Drosophila) |
chr4_-_139163491 | 1.15 |
ENST00000280612.5
|
SLC7A11
|
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
chrX_-_39956656 | 1.14 |
ENST00000397354.3
ENST00000378444.4 |
BCOR
|
BCL6 corepressor |
chr11_-_95657231 | 1.13 |
ENST00000409459.1
ENST00000352297.7 ENST00000393223.3 ENST00000346299.5 |
MTMR2
|
myotubularin related protein 2 |
chr6_+_4890226 | 1.09 |
ENST00000343762.5
|
CDYL
|
chromodomain protein, Y-like |
chr13_-_38172863 | 1.08 |
ENST00000541481.1
ENST00000379743.4 ENST00000379742.4 ENST00000379749.4 ENST00000541179.1 ENST00000379747.4 |
POSTN
|
periostin, osteoblast specific factor |
chr12_+_53848505 | 1.07 |
ENST00000552819.1
ENST00000455667.3 |
PCBP2
|
poly(rC) binding protein 2 |
chr17_-_1395954 | 1.04 |
ENST00000359786.5
|
MYO1C
|
myosin IC |
chr8_-_23712312 | 1.02 |
ENST00000290271.2
|
STC1
|
stanniocalcin 1 |
chr6_+_4021554 | 1.01 |
ENST00000337659.6
|
PRPF4B
|
pre-mRNA processing factor 4B |
chr1_+_114472222 | 1.00 |
ENST00000369558.1
ENST00000369561.4 |
HIPK1
|
homeodomain interacting protein kinase 1 |
chr4_+_57774042 | 0.99 |
ENST00000309042.7
|
REST
|
RE1-silencing transcription factor |
chr7_+_17338239 | 0.98 |
ENST00000242057.4
|
AHR
|
aryl hydrocarbon receptor |
chr20_-_47804894 | 0.95 |
ENST00000371828.3
ENST00000371856.2 ENST00000360426.4 ENST00000347458.5 ENST00000340954.7 ENST00000371802.1 ENST00000371792.1 ENST00000437404.2 |
STAU1
|
staufen double-stranded RNA binding protein 1 |
chr15_-_52861394 | 0.95 |
ENST00000563277.1
ENST00000566423.1 |
ARPP19
|
cAMP-regulated phosphoprotein, 19kDa |
chr3_+_159557637 | 0.94 |
ENST00000445224.2
|
SCHIP1
|
schwannomin interacting protein 1 |
chr3_-_196159268 | 0.94 |
ENST00000381887.3
ENST00000535858.1 ENST00000428095.1 ENST00000296328.4 |
UBXN7
|
UBX domain protein 7 |
chr7_-_91875358 | 0.93 |
ENST00000458177.1
ENST00000394507.1 ENST00000340022.2 ENST00000444960.1 |
KRIT1
|
KRIT1, ankyrin repeat containing |
chr4_+_183164574 | 0.91 |
ENST00000511685.1
|
TENM3
|
teneurin transmembrane protein 3 |
chr9_+_128509624 | 0.91 |
ENST00000342287.5
ENST00000373487.4 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
chr7_+_26191809 | 0.90 |
ENST00000056233.3
|
NFE2L3
|
nuclear factor, erythroid 2-like 3 |
chr19_+_531713 | 0.88 |
ENST00000215574.4
|
CDC34
|
cell division cycle 34 |
chr6_-_90121938 | 0.88 |
ENST00000369415.4
|
RRAGD
|
Ras-related GTP binding D |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
3.7 | 11.1 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
2.7 | 8.2 | GO:0050923 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) regulation of negative chemotaxis(GO:0050923) |
2.4 | 7.3 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
2.4 | 9.7 | GO:0019046 | release from viral latency(GO:0019046) |
1.7 | 7.0 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.6 | 4.8 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
1.5 | 4.5 | GO:0002663 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
1.5 | 4.4 | GO:0060920 | atrioventricular node development(GO:0003162) cardiac pacemaker cell differentiation(GO:0060920) cardiac pacemaker cell development(GO:0060926) |
1.5 | 7.4 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
1.4 | 5.7 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
1.4 | 9.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.4 | 6.9 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
1.2 | 5.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.2 | 16.8 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
1.2 | 4.6 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
1.1 | 12.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
1.1 | 3.3 | GO:0021569 | rhombomere 3 development(GO:0021569) |
1.0 | 1.0 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.9 | 3.7 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.9 | 3.6 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.9 | 2.6 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.9 | 6.0 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.8 | 3.9 | GO:0030047 | actin modification(GO:0030047) |
0.8 | 2.3 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.7 | 8.1 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.7 | 3.5 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.7 | 2.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.7 | 2.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.7 | 2.0 | GO:0003186 | tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) |
0.6 | 2.5 | GO:0030242 | pexophagy(GO:0030242) |
0.6 | 1.9 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.6 | 1.8 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.6 | 3.6 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.6 | 2.3 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.6 | 10.5 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.6 | 7.8 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.6 | 1.7 | GO:0032101 | regulation of response to external stimulus(GO:0032101) |
0.6 | 1.7 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.5 | 10.3 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.5 | 1.6 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.5 | 1.9 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.5 | 2.4 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.5 | 1.4 | GO:0044805 | late nucleophagy(GO:0044805) |
0.5 | 7.3 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.4 | 7.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.4 | 2.5 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.4 | 12.5 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.4 | 5.4 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.4 | 0.8 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.4 | 0.8 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.4 | 2.3 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.4 | 1.8 | GO:0034971 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) histone H3-R17 methylation(GO:0034971) |
0.4 | 5.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.4 | 1.1 | GO:1990523 | bone regeneration(GO:1990523) |
0.4 | 4.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.4 | 5.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 2.3 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
0.3 | 1.9 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.3 | 4.5 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.3 | 6.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 3.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.3 | 1.6 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.3 | 14.3 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.3 | 2.2 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.3 | 2.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.3 | 5.3 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.3 | 0.9 | GO:2000282 | negative regulation of cardiac muscle adaptation(GO:0010616) regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) regulation of cellular amino acid biosynthetic process(GO:2000282) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.3 | 1.4 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.3 | 1.1 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.3 | 0.8 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.3 | 0.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.3 | 1.9 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
0.3 | 8.7 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.3 | 5.1 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.3 | 7.0 | GO:0007567 | parturition(GO:0007567) |
0.3 | 4.0 | GO:0010225 | response to UV-C(GO:0010225) |
0.3 | 1.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.3 | 1.6 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.3 | 3.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.3 | 4.4 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.3 | 1.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.2 | 2.2 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.2 | 3.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.2 | 10.6 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
0.2 | 8.7 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.2 | 16.9 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.2 | 2.5 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.2 | 11.5 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.2 | 2.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 3.3 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.2 | 0.6 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 11.4 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) regulation of glutamate receptor signaling pathway(GO:1900449) |
0.2 | 2.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.2 | 0.6 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 4.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 1.7 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 0.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.2 | 0.7 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 0.7 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 0.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 1.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 2.5 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 1.0 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.2 | 13.2 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.2 | 0.3 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.2 | 1.9 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.8 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 1.2 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.2 | 3.9 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 1.9 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 6.2 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.9 | GO:0071233 | cellular response to leucine(GO:0071233) cellular response to leucine starvation(GO:1990253) |
0.1 | 0.4 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.1 | 0.9 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 5.9 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 2.4 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 1.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 1.2 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.1 | 10.1 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 0.5 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 4.7 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 6.8 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) |
0.1 | 1.0 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.1 | 1.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.2 | GO:0051461 | regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 18.7 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.3 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.1 | 1.0 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.1 | 0.9 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 0.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.3 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.1 | 3.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 1.6 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.1 | 5.0 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 3.9 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.1 | 1.9 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.2 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 0.2 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.1 | 1.1 | GO:0002190 | cap-independent translational initiation(GO:0002190) IRES-dependent translational initiation(GO:0002192) IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 0.1 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.1 | 11.8 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.1 | 0.9 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 1.4 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 1.8 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.1 | 1.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 8.2 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.1 | 4.9 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 3.5 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.1 | 4.3 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
0.1 | 0.2 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 1.8 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 10.4 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.5 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 1.3 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 0.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 1.2 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 1.2 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.4 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.4 | GO:0033197 | response to vitamin E(GO:0033197) |
0.0 | 0.7 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 1.3 | GO:0030335 | positive regulation of cell migration(GO:0030335) |
0.0 | 1.6 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.0 | 1.2 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.0 | 3.8 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.0 | 0.8 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.5 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.0 | 0.2 | GO:0061046 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) primary lung bud formation(GO:0060431) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.0 | 4.2 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 1.4 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 1.6 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.3 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.3 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 1.0 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
0.0 | 1.8 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.0 | 0.8 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 0.2 | GO:0090003 | regulation of establishment of protein localization to plasma membrane(GO:0090003) |
0.0 | 0.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.6 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.0 | 0.7 | GO:0021762 | substantia nigra development(GO:0021762) |
0.0 | 1.5 | GO:0006023 | aminoglycan biosynthetic process(GO:0006023) glycosaminoglycan biosynthetic process(GO:0006024) |
0.0 | 0.8 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 1.4 | GO:0051168 | nuclear export(GO:0051168) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 7.4 | GO:0032301 | MutSalpha complex(GO:0032301) |
1.7 | 5.0 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
1.1 | 15.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.0 | 9.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.0 | 3.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.9 | 4.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.8 | 3.9 | GO:0097422 | tubular endosome(GO:0097422) |
0.7 | 3.7 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.7 | 4.5 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) |
0.7 | 2.1 | GO:0019034 | viral replication complex(GO:0019034) |
0.7 | 10.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.7 | 12.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.6 | 1.9 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.6 | 2.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.5 | 2.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.5 | 3.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.5 | 4.5 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.5 | 5.7 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.5 | 10.7 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.4 | 11.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.4 | 2.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.4 | 9.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.4 | 4.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 6.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.4 | 1.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.3 | 3.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 2.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 11.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.3 | 2.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.3 | 2.5 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.3 | 3.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 1.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.3 | 4.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 1.7 | GO:0001740 | Barr body(GO:0001740) |
0.3 | 1.9 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 2.4 | GO:0000125 | PCAF complex(GO:0000125) |
0.3 | 1.0 | GO:0045160 | myosin I complex(GO:0045160) |
0.3 | 3.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 1.0 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.2 | 0.7 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 1.9 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 2.3 | GO:0005688 | U6 snRNP(GO:0005688) |
0.2 | 2.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 1.8 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 3.4 | GO:0032059 | bleb(GO:0032059) |
0.2 | 6.7 | GO:0090544 | BAF-type complex(GO:0090544) |
0.2 | 3.6 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.2 | 2.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 10.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 15.7 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 2.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 3.9 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 2.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.9 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 9.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 5.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 7.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 3.6 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 1.8 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 5.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 4.5 | GO:0000792 | heterochromatin(GO:0000792) |
0.1 | 6.9 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 11.5 | GO:0016605 | PML body(GO:0016605) |
0.1 | 2.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 2.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 2.7 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 6.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.6 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.3 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.1 | 0.8 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 1.6 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 1.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 4.4 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.2 | GO:0051286 | cell tip(GO:0051286) |
0.0 | 0.7 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 2.1 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 6.0 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 9.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 9.3 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.6 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 8.6 | GO:0043292 | contractile fiber(GO:0043292) |
0.0 | 0.9 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 8.7 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 1.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 1.9 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 2.8 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 8.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 1.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 2.8 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.4 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 1.1 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 11.5 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 0.8 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 3.3 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.2 | GO:1990752 | microtubule end(GO:1990752) |
0.0 | 0.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.5 | GO:0005811 | lipid particle(GO:0005811) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 16.8 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
2.5 | 7.4 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
1.9 | 5.7 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
1.8 | 7.4 | GO:0032143 | single thymine insertion binding(GO:0032143) |
1.8 | 5.4 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
1.7 | 15.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.7 | 5.1 | GO:0032427 | GBD domain binding(GO:0032427) |
1.4 | 13.9 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.4 | 8.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.3 | 7.8 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.2 | 7.3 | GO:0035500 | MH2 domain binding(GO:0035500) |
1.1 | 11.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.1 | 4.5 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
1.0 | 7.0 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.9 | 10.6 | GO:0031386 | protein tag(GO:0031386) |
0.7 | 3.5 | GO:0034046 | poly(G) binding(GO:0034046) |
0.6 | 6.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.6 | 2.4 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.6 | 8.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.6 | 7.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.5 | 9.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.5 | 8.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.5 | 10.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.4 | 4.5 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.4 | 3.9 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.4 | 2.5 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.4 | 2.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.4 | 3.4 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 4.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 2.0 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.3 | 10.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 1.3 | GO:0038025 | reelin receptor activity(GO:0038025) |
0.3 | 2.6 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 4.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 12.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.3 | 1.5 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.3 | 13.4 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.3 | 0.9 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.3 | 1.6 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.3 | 0.8 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.3 | 11.1 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.3 | 3.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 13.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 1.0 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.2 | 1.9 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 1.2 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
0.2 | 1.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 3.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 3.3 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.2 | 6.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 9.9 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 1.8 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 17.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 0.6 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 2.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 2.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 1.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 1.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 4.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 5.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 0.8 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 5.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 7.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 1.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 2.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 5.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 6.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.3 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 4.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 20.7 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 1.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 3.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 4.6 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 11.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 2.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 4.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 4.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 3.9 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 2.0 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 7.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 1.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 1.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 3.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 2.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 1.1 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 0.8 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.1 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 3.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 6.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 6.3 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 11.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.5 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.1 | 1.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 7.5 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.1 | 3.4 | GO:0070035 | ATP-dependent RNA helicase activity(GO:0004004) ATP-dependent helicase activity(GO:0008026) RNA-dependent ATPase activity(GO:0008186) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 4.1 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 2.4 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 3.7 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.3 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 15.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 2.7 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 1.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.9 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 5.0 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 1.2 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.1 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 1.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 2.5 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 6.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 19.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.3 | 23.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 12.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 17.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 3.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 4.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 2.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 12.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 2.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 4.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 4.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 4.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 3.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 2.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 4.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 5.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 2.4 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 7.0 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 3.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 5.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 8.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 1.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 1.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 9.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 1.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 1.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 2.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 3.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 2.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 1.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 5.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 8.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.4 | 12.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.4 | 7.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.4 | 4.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.4 | 15.7 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.4 | 5.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 12.9 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.3 | 7.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 20.0 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.2 | 5.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 7.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 7.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 2.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 5.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.9 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 4.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 6.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 1.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 3.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 7.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 4.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 16.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 7.1 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 3.7 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 1.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 2.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 2.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 8.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 7.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 3.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 4.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 4.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 1.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.6 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 2.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.2 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.8 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |